In compliance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity has disclosed all relevant financial relationships with any commercial interest. All reported conflicts are managed by a designated official to ensure a bias-free presentation. Please see the insert to this program, for the complete disclosure list.
Ineligible Company
Defined by the ACCME as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
Financial Relationships
Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.
Faculty Disclosures
Speakers
Daniel Buckland, MD, MS, PhD — Nothing to disclose
Lawrence Carin, PhD — Nothing to disclose
David Dov, PhD — Nothing to disclose
Timothy W. Dunn, PhD — Nothing to disclose
Nita Farahany, PhD, JD — Illumina, Consulting, Consultant Fees; Helix, Consulting, Consultant Fees
Teodor Grantcharov, MD, PhD, FACS — SST Inc., Founder, IP & Salary
Daniel Hashimoto, MD, FACS — Johnson & Johnson, Consulting, Consultant Fees; Verily Life Sciences, Consultant; Worrell, Consultant; Olympus Corporation, Sponsored Research Agreement, Research Support; McGraw Hill Education, Textbook Editor, Royalty Agreement
Ricardo Henao, PhD — Nothing to disclose
Erich S. Huang, MD, PhD — kelaHealth, Founder, Equity; Stratus Medicine, Founder, Equity; Clinetic, Founder, Equity, Optimize Health, Advisor, Equity; Valo Health, Consulting, Consulting Fee
Eun Sil Shelly Hwang, MD, FACS — Nothing to disclose
Allan D. Kirk, MD, PhD, FACS — Clinetic, Board Chair, Stock; CareDX, Consulting, FMV Consulting Fees; Sanofi, Consulting, FMV Consulting Fees; Eurofins, Consulting, FMV Consulting Fees; Vertex, Consulting, FMV Consulting Fees; Novartis, Consulting, FMV Consulting Fees
Carla M. Pugh, MD, PhD, FACS — Medical Teaching Systems, Founder, Personal Financial Investment; 10 Newtons, Inc, Founder, Personal Financial Investment; 10 Newtons Women’s Wellness Foundation, Founder, Personal Financial Investment; Intuitive Surgical Foundation, Consulting, Consulting Fees; PrecisionOS, Consulting, Consulting Fees
Danielle Elliott Range, MD — Nothing to disclose
Guy Rosman, PhD — Toyota Research Institute, Senior Research Scientist, Salary; Von Bispharma, Senior Research Scientist, Salary; Olympus, Consultant, Consulting Fees
Frank Rudzicz, PhD — Surgical Safety Technologies Inc, Director of AI, Salary
Ajit K. Sachdeva, MD, FACS, FRCSC, FSACME — Nothing to disclose
Planning Committee
Patrice Gabler Blair, DrPH, MPH — Nothing to disclose
Allan D. Kirk, MD, PhD, FACS — Clinetic, Board Chair, Stock; CareDX, Consulting, FMV Consulting Fees; Sanofi, Consulting, FMV Consulting Fees; Eurofins, Consulting, FMV Consulting Fees; Vertex, Consulting, FMV Consulting Fees; Novartis, Consulting, FMV Consulting Fees
Ajit K. Sachdeva, MD, FACS, FRCSC, FSACME — Nothing to disclose
